RMDI
BMY icon

R.M. Davis Inc’s Bristol-Myers Squibb BMY Stock Holding History

R.M. Davis Inc’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$257K Buy
+4,245
New +$247K ﹤0.01% 250
2025
Q3 		– Sell
-4,326
Closed -$200K – 275
2025
Q2 		$200K Sell
4,326
-3,178
-42% -$156K ﹤0.01% 267
2025
Q1 		$458K Buy
7,504
+1,674
+29% +$97.6K 0.01% 211
2024
Q4 		$330K Sell
5,830
-1,065
-15% -$59.5K 0.01% 229
2024
Q3 		$357K Sell
6,895
-2,474
-26% -$116K 0.01% 223
2024
Q2 		$389K Buy
9,369
+225
+2% +$10.1K 0.01% 218
2024
Q1 		$496K Sell
9,144
-145
-2% -$7.39K 0.01% 184
2023
Q4 		$477K Sell
9,289
-1,223
-12% -$64.2K 0.01% 188
2023
Q3 		$610K Sell
10,512
-1,371
-12% -$84K 0.02% 166
2023
Q2 		$760K Buy
11,883
+1,289
+12% +$86.4K 0.02% 160
2023
Q1 		$734K Buy
10,594
+65
+0.6% +$4.58K 0.02% 158
2022
Q4 		$758K Buy
10,529
+590
+6% +$44.5K 0.02% 155
2022
Q3 		$707K Buy
9,939
+100
+1% +$7.25K 0.02% 160
2022
Q2 		$758K Buy
9,839
+958
+11% +$73K 0.02% 155
2022
Q1 		$649K Buy
8,881
+638
+8% +$42.8K 0.02% 168
2021
Q4 		$514K Sell
8,243
-1
-0% -$59 0.01% 180
2021
Q3 		$488K Sell
8,244
-282
-3% -$18.6K 0.01% 174
2021
Q2 		$570K Buy
8,526
+585
+7% +$38.1K 0.01% 167
2021
Q1 		$501K Sell
7,941
-1,885
-19% -$117K 0.01% 170
2020
Q4 		$610K Buy
9,826
+354
+4% +$21.8K 0.02% 166
2020
Q3 		$571K Sell
9,472
-1,428
-13% -$85.9K 0.02% 157
2020
Q2 		$641K Sell
10,900
-1,162
-10% -$69.5K 0.02% 146
2020
Q1 		$672K Buy
12,062
+266
+2% +$16.3K 0.03% 140
2019
Q4 		$757K Sell
11,796
-598
-5% -$34.2K 0.02% 143
2019
Q3 		$628K Sell
12,394
-548
-4% -$25.8K 0.02% 145
2019
Q2 		$587K Sell
12,942
-1,151
-8% -$53.6K 0.02% 152
2019
Q1 		$672K Sell
14,093
-275
-2% -$13.7K 0.03% 148
2018
Q4 		$747K Sell
14,368
-2,720
-16% -$146K 0.03% 141
2018
Q3 		$1.06M Sell
17,088
-229
-1% -$13.6K 0.04% 130
2018
Q2 		$958K Sell
17,317
-2,618
-13% -$141K 0.04% 131
2018
Q1 		$1.26M Sell
19,935
-1,242
-6% -$79.9K 0.05% 124
2017
Q4 		$1.3M Sell
21,177
-800
-4% -$50K 0.05% 120
2017
Q3 		$1.4M Buy
21,977
+1,549
+8% +$90.4K 0.06% 114
2017
Q2 		$1.14M Sell
20,428
-7,250
-26% -$395K 0.05% 119
2017
Q1 		$1.5M Sell
27,678
-1,729
-6% -$94.8K 0.07% 110
2016
Q4 		$1.72M Buy
29,407
+6,820
+30% +$373K 0.08% 106
2016
Q3 		$1.22M Sell
22,587
-433
-2% -$27.8K 0.06% 113
2016
Q2 		$1.69M Buy
23,020
+1,600
+7% +$113K 0.08% 104
2016
Q1 		$1.37M Buy
21,420
+259
+1% +$16.3K 0.07% 106
2015
Q4 		$1.46M Sell
21,161
-887
-4% -$58.6K 0.07% 108
2015
Q3 		$1.3M Buy
22,048
+386
+2% +$24.5K 0.07% 115
2015
Q2 		$1.44M Buy
21,662
+2,872
+15% +$189K 0.07% 111
2015
Q1 		$1.21M Sell
18,790
-651
-3% -$40.8K 0.06% 111
2014
Q4 		$1.15M Buy
19,441
+900
+5% +$50.8K 0.06% 113
2014
Q3 		$949K Sell
18,541
-1,875
-9% -$93.7K 0.05% 119
2014
Q2 		$990K Buy
20,416
+5,232
+34% +$258K 0.06% 114
2014
Q1 		$789K Sell
15,184
-1,633
-10% -$86.9K 0.05% 120
2013
Q4 		$894K Buy
16,817
+1,154
+7% +$58.8K 0.05% 115
2013
Q3 		$725K Sell
15,663
-1,799
-10% -$79K 0.05% 116
2013
Q2 		$780K Buy
+17,462
New +$758K 0.06% 115

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

R.M. Davis Inc's BMY Position: Q1 2026 in Review

R.M. Davis Inc opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 4,245 shares worth $257K. The stake represents ﹤0.01% of the portfolio and ranks #250 among its holdings. This is a return to the name: R.M. Davis Inc previously reported a position in BMY as recently as Q2 2025.

R.M. Davis Inc first reported a position in BMY in Q2 2013 and has held it in 50 quarters since. The position peaked at $1.72M in Q4 2016. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • R.M. Davis Inc held 4,245 shares of Bristol-Myers Squibb worth $257K as of Q1 2026.
  • Bristol-Myers Squibb was a new R.M. Davis Inc position in Q1 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of R.M. Davis Inc's portfolio in Q1 2026, its #250 holding.
  • R.M. Davis Inc first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 50 quarters since.
  • R.M. Davis Inc's Bristol-Myers Squibb position peaked at $1.72M in Q4 2016.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on R.M. Davis Inc's 13F filing for Q1 2026, filed 13 May 2026.